HomeZYDUSLIFE • NSE
add
Zydus Lifesciences Ltd
Nakaraang pagsara
₹989.95
Sakop ng araw
₹986.35 - ₹1,004.60
Sakop ng taon
₹795.00 - ₹1,324.30
Market cap
1.00T INR
Average na Volume
1.12M
P/E ratio
22.32
Dividend yield
1.10%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Kita | 65.28B | 17.96% |
Gastos sa pagpapatakbo | 29.04B | 24.26% |
Net na kita | 11.71B | -0.96% |
Net profit margin | 17.94 | -16.01% |
Kita sa bawat share | 13.27 | 13.80% |
EBITDA | 21.56B | 34.80% |
Aktuwal na % ng binabayarang buwis | 25.39% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 78.08B | 475.13% |
Kabuuang asset | 372.02B | 27.05% |
Kabuuang sagutin | 108.43B | 51.04% |
Kabuuang equity | 263.58B | — |
Natitirang share | 1.01B | — |
Presyo para makapag-book | 4.16 | — |
Return on assets | — | — |
Return on capital | 17.87% | — |
Cash Flow
Net change in cash
(INR) | Mar 2025info | Y/Y na pagbabago |
---|---|---|
Net na kita | 11.71B | -0.96% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
Itinatag
1952
Website
Mga Empleyado
26,921